MedInvest, a leading healthcare, biotech, and medtech media and conference company, will host its semi-annual Biotech and Pharma Investor Conference in New York City, NY on March 27-28, 2025.  The National Institutes of Health and Cooley Law Firm will be presenting partners of the event.

 

The conference is expected to attract 125+ investors spanning venture and public funds, family offices, strategics, and government and non-profit grant making entities. The two-day event will consist of half a dozen talks by KOLs and investor panels.

 

During, before and after the conference for two weeks, meetings will be facilitated both in person and virtually via the conference’s partnering system.

​

Speakers include:

Dennis Purcell, Founder, Aisling Capital and Former Managing Director of Healthcare Investment Banking at JP Morgan H&Q

Dr. Alfred Slanetz, Chairman of the National Foundation for Cancer Research and Former CEO iof Bluebird Bio

Ario Arabi, Executive Director, Business Development & Licensing, Novartis

Dr. Themasap Khan, Founder of the Luma Group

Allan Gobbs, Founder of ATEM Capital

Rick Lipkin, Founder of the Catalytic Impact Foundation

Alex Kruszewski, Chief Investment Officer, Goldfinch Family Office

Sergei Petukhov, Founder, Ludicrous Ventures

Dr. Lynda Chin, Founding Director of the Department of Genomic Medicine, MD Anderson

Steven Ferguson, Deputy Director, Licensing and Entrepreneurship, NIH

Dr. Michael Salgaller, Director of the Invention Development and Marketing Unit, NCI

Josh Seidenfeld, Partner, Cooley